title: ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).
abstract: To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferences to better clarify open issues in each disease. In this setting, a consensus conference on the management of lymphoma was held on 18 June 2011 in Lugano, immediately after the end of the 11th International Conference on Malignant Lymphoma. The consensus conference convened ∼45 experts from all around Europe and selected six lymphoma entities to be addressed; for each of them three to five open questions were to be discussed by the experts. For each question, a recommendation should be given by the panel, supported by the strength of the recommendation based on the level of evidence. This consensus report focuses on the three most common lymphoproliferative malignancies: diffuse large B-cell lymphoma, follicular lymphoma and chronic lymphocytic leukemia. A second report will concentrate on mantle cell lymphoma, marginal zone lymphoma and T-cell lymphomas.
authors.affiliation: Department of Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. mghielmini@ticino.com
authors.forename: M
authors.initials: M
authors.lastname: Ghielmini
authors.forename: U
authors.initials: U
authors.lastname: Vitolo
authors.forename: E
authors.initials: E
authors.lastname: Kimby
authors.forename: S
authors.initials: S
authors.lastname: Montoto
authors.forename: J
authors.initials: J
authors.lastname: Walewski
authors.forename: M
authors.initials: M
authors.lastname: Pfreundschuh
authors.forename: M
authors.initials: M
authors.lastname: Federico
authors.forename: P
authors.initials: P
authors.lastname: Hoskin
authors.forename: C
authors.initials: C
authors.lastname: McNamara
authors.forename: F
authors.initials: F
authors.lastname: Caligaris-Cappio
authors.forename: S
authors.initials: S
authors.lastname: Stilgenbauer
authors.forename: R
authors.initials: R
authors.lastname: Marcus
authors.forename: M
authors.initials: M
authors.lastname: Trneny
authors.forename: P
authors.initials: P
authors.lastname: Dreger
authors.forename: E
authors.initials: E
authors.lastname: Montserrat
authors.forename: M
authors.initials: M
authors.lastname: Dreyling
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D019468:Disease Management; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D017410:Practice Guidelines as Topic; D033581:Stem Cell Transplantation